These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 10421612)

  • 1. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
    Cvetkovic M; Leake B; Fromm MF; Wilkinson GR; Kim RB
    Drug Metab Dispos; 1999 Aug; 27(8):866-71. PubMed ID: 10421612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion.
    Tahara H; Kusuhara H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2005 Jul; 33(7):963-8. PubMed ID: 15821041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
    Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
    Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B
    J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
    Ming X; Knight BM; Thakker DR
    Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide.
    Tong Y; Zhang R; Ngo SN; Davey AK
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):685-9. PubMed ID: 16895540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats.
    Qiang F; Lee BJ; Lee W; Han HK
    Eur J Pharm Sci; 2009 Jun; 37(3-4):413-7. PubMed ID: 19428223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
    Ujie K; Oda M; Kobayashi M; Saitoh H
    Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents.
    Hashiguchi Y; Hamada A; Shinohara T; Tsuchiya K; Jono H; Saito H
    Biochem Biophys Res Commun; 2013 Sep; 439(2):221-7. PubMed ID: 23981805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat.
    Garver E; Hugger ED; Shearn SP; Rao A; Dawson PA; Davis CB; Han C
    Drug Metab Dispos; 2008 Dec; 36(12):2492-8. PubMed ID: 18755851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
    Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
    Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
    Shirasaka Y; Kuraoka E; Spahn-Langguth H; Nakanishi T; Langguth P; Tamai I
    J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.
    Smith BJ; Doran AC; McLean S; Tingley FD; O'Neill BT; Kajiji SM
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1252-9. PubMed ID: 11504828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
    Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
    Kamath AV; Yao M; Zhang Y; Chong S
    J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
    Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
    Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.